Drug Shortage Report for FUROSEMIDE INJECTION SDZ

Last updated on 2019-06-28 History
Report ID 86417
Drug Identification Number 02382539
Brand name FUROSEMIDE INJECTION SDZ
Common or Proper name FUROSEMIDE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) FUROSEMIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 2ml X 10
ATC code C03CA
ATC description HIGH-CEILING DIURETICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-06-03
Estimated end date 2019-06-17
Actual end date 2019-06-14
Shortage status Resolved
Updated date 2019-06-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-06-28 French Compare
v3 2019-06-28 English Compare
v2 2019-06-12 French Compare
v1 2019-06-12 English Compare

Showing 1 to 4 of 4